Asking the right questions around AI, with Brian Alexander, Valo Health

Finding a conversation about AI at a conference like BIO 2025 is easy. But making those conversations meaningful and asking the right questions that advance and move forward the field hasn’t always been.

At last month’s show, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve at shows like this into something generally more productive. Alexander also describes the work his own company is doing reimagining drug development for the current world of reliable AI and robust, large data sets.

Alexander shares his take that the ultimate differentiator is not going to be data quality, but instead the ability to extract valuable knowledge and insights from large data sets. He also talks a bit (without sharing details, of course) about his company’s partnership with Novo Nordisk and how they’re helping the Danish pharma giant look for insights in their own large data sets.

Check out the video below for a fascinating conversation with an emerging AI biotech leader. And watch other videos from BIO here.